| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.86 | 0.0002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |